Dr. Dipti Itchhaporia, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- Saint Louis University School of Medicine (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,572
Licensed in California since 1989, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: Saint Louis University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
CA license G66492 (first issued 1989; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hoag Memorial Hospital Presbyterian Newport Beach, CA
Medical groups
- Dipti Itchhaporia Medical Corporation (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,572
- Services billed
- 21,094
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Injection, inclisiran, 1 mg | 3,692 | 11 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 2,265 | 51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,458 | 1,250 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,441 | 1,086 |
| Established patient office or other outpatient visit, 20-29 minutes | 610 | 546 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 603 | 584 |
| Infusion, normal saline solution, 250 cc | 312 | 78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 221 | 115 |
| Programming of dual lead pacemaker system | 200 | 117 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 156 | 78 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Rosuvastatin Calcium Other prescribers in Newport Beach, CA | 531 |
| Eliquis (apixaban) Other prescribers in Newport Beach, CA | 412 |
| Metoprolol Succinate Other prescribers in Newport Beach, CA | 411 |
| Atorvastatin Calcium Other prescribers in Newport Beach, CA | 333 |
| Losartan Potassium Other prescribers in Newport Beach, CA | 264 |
| Amlodipine Besylate Other prescribers in Newport Beach, CA | 231 |
| Ezetimibe Other prescribers in Newport Beach, CA | 229 |
| Amiodarone Hcl Other prescribers in Newport Beach, CA | 160 |
| Jardiance (empagliflozin) Other prescribers in Newport Beach, CA | 136 |
| Xarelto (rivaroxaban) Other prescribers in Newport Beach, CA | 107 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 32 payments worth $1,097 in total to this clinician.
| Amgen Inc. | $183 |
|---|---|
| Janssen Biotech, Inc. | $135 |
| E.r. Squibb & Sons, L.l.c. | $113 |
| Novartis Pharmaceuticals Corporation | $109 |
| Merck Sharp & Dohme LLC | $84.66 |
| Novo Nordisk Inc | $78.34 |
| Bridgebio Pharma, Inc. | $69.64 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $69.20 |
| Food and Beverage | $1,097 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.